Bonanza of new treatment regimens for multiple myeloma: What is right for my patient?

Research output: Contribution to journalReview articlepeer-review

Abstract

Although recent advances in the treatment of multiple myeloma have improved survival, it remains a chronic disease that requires a long-term treatment strategy. The key to achieving the best outcomes for patients is delivering the best “package” of treatment at a given stage. This means using optimal combinations that maximize benefit based on what patients have received previously and minimize treatment-related toxicity. Sequencing of regimens also plays an important role. As new agents and new classes of drugs continue to be approved for multiple myeloma, future strategies will use more individualized approaches to treatment.

Original languageEnglish (US)
Pages (from-to)1773-1776
Number of pages4
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume18
DOIs
StatePublished - Dec 2020

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Bonanza of new treatment regimens for multiple myeloma: What is right for my patient?'. Together they form a unique fingerprint.

Cite this